According to Nautilus Biotechnology's latest financial reports the company's current EPS (TTM) is -$0.78. In 2022 the company made an earnings per share (EPS) of -$0.75 an increase over its 2021 EPS that were of -$0.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.74 | -0.83% |
2022 | -$0.75 | -7.44% |
2021 | -$0.80 |